|
US2016058709A1
|
|
Plurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
|
|
UA118711C2
|
|
Plurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
|
|
US2015025032A1
|
|
Composition for the management of nausea and vomiting
|
|
BR112016001474A2
|
|
COMPOSITION FOR THE CONTROL OF NAUSEA AND VOMITING
|
|
CA2848798A1
|
|
Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
|
|
WO2013123569A1
|
|
Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
|
|
JP2007302688A
|
|
Quick-acting formulation
|
|
AU2004266741A1
|
|
Childproof micronutrient supplement
|
|
CA2478278A1
|
|
Micronutrient supplement
|
|
CA2478163A1
|
|
Childproof micronutrient supplement
|
|
WO2005018652A1
|
|
Micronutrient supplement
|
|
CA2432945A1
|
|
Use of doxylamime succinate and pyridoxine hydrochloride for prophylaxis and treatment of post-surgical vomiting
|
|
US2005004181A1
|
|
Use of anti-emetic for pre and post operative care
|
|
CA2432349A1
|
|
Use of anti-emetic for pre and post operative care
|
|
ZA200300594B
|
|
Rapid onset formulation.
|
|
CA2406592A1
|
|
Method of preparing pharmaceutical dosage forms containing multiple active ingredients
|
|
CA2392486A1
|
|
Pharmaceutical dosage form bearing pregnancy-friendly indicia
|
|
TWI301414B
|
|
Rapid onset medical composition and manufacturing method
|
|
ES2229876A1
|
|
QUICK ACTION FORMULATION.
|
|
NZ519709A
|
|
Rapid onset formulation comprising pyridoxine HCL and doxylamine succinate
|
